176 related articles for article (PubMed ID: 38645895)
21. PhenX measures for phenotyping rare genetic conditions.
Phillips M; Grant T; Giampietro P; Bodurtha J; Valdez R; Maiese DR; Hendershot T; Terry SF; Hamilton CM
Genet Med; 2017 Jul; 19(7):834-837. PubMed ID: 28079902
[TBL] [Abstract][Full Text] [Related]
22. PhenX: Agent measures for tobacco regulatory research.
O'Connor R; Watson CH; Swan GE; Nettles DS; Geisler RC; Hendershot TP;
Tob Control; 2020 Jan; 29(Suppl 1):s20-s26. PubMed ID: 31992660
[TBL] [Abstract][Full Text] [Related]
23. Using PhenX measures to identify opportunities for cross-study analysis.
Pan H; Tryka KA; Vreeman DJ; Huggins W; Phillips MJ; Mehta JP; Phillips JH; McDonald CJ; Junkins HA; Ramos EM; Hamilton CM
Hum Mutat; 2012 May; 33(5):849-57. PubMed ID: 22415805
[TBL] [Abstract][Full Text] [Related]
24. PhenX: Host: Social/Cognitive measures for tobacco regulatory research.
Piper ME; Brown DC; Hendershot TP; Swan GE;
Tob Control; 2020 Jan; 29(Suppl 1):s5-s12. PubMed ID: 31992658
[TBL] [Abstract][Full Text] [Related]
25. PhenX RISING: real world implementation and sharing of PhenX measures.
McCarty CA; Huggins W; Aiello AE; Bilder RM; Hariri A; Jernigan TL; Newman E; Sanghera DK; Strauman TJ; Zeng Y; Ramos EM; Junkins HA;
BMC Med Genomics; 2014 Mar; 7():16. PubMed ID: 24650325
[TBL] [Abstract][Full Text] [Related]
26. Validation of PhenX measures in the personalized medicine research project for use in gene/environment studies.
McCarty CA; Berg R; Rottscheit CM; Waudby CJ; Kitchner T; Brilliant M; Ritchie MD
BMC Med Genomics; 2014 Jan; 7():3. PubMed ID: 24423110
[TBL] [Abstract][Full Text] [Related]
27. Interventions to reduce harm from continued tobacco use.
Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465
[TBL] [Abstract][Full Text] [Related]
28. PhenX: Environment measures for Tobacco Regulatory Research.
Unger JB; Chaloupka FJ; Vallone D; Thrasher JF; Nettles DS; Hendershot TP; Swan GE;
Tob Control; 2020 Jan; 29(Suppl 1):s35-s42. PubMed ID: 31992662
[TBL] [Abstract][Full Text] [Related]
29. Building a biomedical cyberinfrastructure for collaborative research.
Schad PA; Mobley LR; Hamilton CM
Am J Prev Med; 2011 May; 40(5 Suppl 2):S144-50. PubMed ID: 21521587
[TBL] [Abstract][Full Text] [Related]
30. Heated tobacco products for smoking cessation and reducing smoking prevalence.
Tattan-Birch H; Hartmann-Boyce J; Kock L; Simonavicius E; Brose L; Jackson S; Shahab L; Brown J
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013790. PubMed ID: 34988969
[TBL] [Abstract][Full Text] [Related]
31. Mindfulness for smoking cessation.
Jackson S; Brown J; Norris E; Livingstone-Banks J; Hayes E; Lindson N
Cochrane Database Syst Rev; 2022 Apr; 4(4):CD013696. PubMed ID: 35420700
[TBL] [Abstract][Full Text] [Related]
32. Tobacco packaging design for reducing tobacco use.
McNeill A; Gravely S; Hitchman SC; Bauld L; Hammond D; Hartmann-Boyce J
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011244. PubMed ID: 28447363
[TBL] [Abstract][Full Text] [Related]
33. Interventions for waterpipe smoking cessation.
Maziak W; Jawad M; Jawad S; Ward KD; Eissenberg T; Asfar T
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD005549. PubMed ID: 26228266
[TBL] [Abstract][Full Text] [Related]
34. Biomedical risk assessment as an aid for smoking cessation.
Clair C; Mueller Y; Livingstone-Banks J; Burnand B; Camain JY; Cornuz J; Rège-Walther M; Selby K; Bize R
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD004705. PubMed ID: 30912847
[TBL] [Abstract][Full Text] [Related]
35. Strategies to improve smoking cessation rates in primary care.
Lindson N; Pritchard G; Hong B; Fanshawe TR; Pipe A; Papadakis S
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD011556. PubMed ID: 34693994
[TBL] [Abstract][Full Text] [Related]
36. Smoking reduction interventions for smoking cessation.
Lindson N; Klemperer E; Hong B; Ordóñez-Mena JM; Aveyard P
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD013183. PubMed ID: 31565800
[TBL] [Abstract][Full Text] [Related]
37. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
Ekpu VU; Brown AK
Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
[TBL] [Abstract][Full Text] [Related]
38. Mental health service user and staff perspectives on tobacco addiction and smoking cessation: A meta-synthesis of published qualitative studies.
Malone V; Harrison R; Daker-White G
J Psychiatr Ment Health Nurs; 2018 May; 25(4):270-282. PubMed ID: 29498459
[TBL] [Abstract][Full Text] [Related]
39. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
